|
Volumn 24, Issue 12, 2005, Pages 1493-1497
|
Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CHOP PROTOCOL;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPOCH PROTOCOL;
ETOPOSIDE;
PREDNISONE;
VINCRISTINE;
ADOLESCENT;
ADULT;
AGED;
ANEMIA;
ARTICLE;
CANCER STAGING;
CHEMICALLY INDUCED DISORDER;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NATURAL KILLER CELL;
NEUTROPENIA;
NOSE TUMOR;
PATHOLOGY;
PROGNOSIS;
REMISSION;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
T CELL LYMPHOMA;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANEMIA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
FEMALE;
HUMANS;
KILLER CELLS, NATURAL;
LYMPHOMA, T-CELL;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
NEUTROPENIA;
NOSE NEOPLASMS;
PREDNISONE;
PROGNOSIS;
REMISSION INDUCTION;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
VINCRISTINE;
|
EID: 34548456926
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|